N5334 CASE STUDY 2 DIABETIC CASE STUDY 1 Diabetic Case Study N5334 Advanced Pharmacology for APNs L

In partial fulfillment of the requirements of N5334 Advanced Pharmacology for APNs Lynda Jarrell, DNP, APRN, FNP-BC, CNE 6/25/2 0 This study source was downloaded by from CourseH on :47:26 GMT -05:00 DIABETIC CASE STUDY 2 Assessment 1. DM Type 2. HTN 3. Hyperlipidemia 4. Obesity Treatment Plan Pharmacologic: 1. Aspirin 81 mg by mouth once daily (Arnett et al., 2019) 2. Metformin IR 500 mg by mouth once daily (Wexler, 2020) 3. Atorvastatin 40 mg by mouth once daily (Rosenson, 2020) 4. Lisinopril 5 mg by mouth once daily (Mann, 2020) Provide rationale: 1. Aspirin 81 mg by mouth once daily; According to The American College of Cardiology, “Low dose aspirin is considered to be primary prevention of cardiovascular disease among select adults 40 to 70 years of age who are at higher risk of ASCVD risk but not at risk for increased bleeding” (Arnett et al., 2019) 2. Metformin IR 500 mg by mouth once daily; According to Up to Date, “Metformin is the initial medication of choice for hyperglycemia in type 2 diabetes along with lifestyle interventions at the time of diagnosis” (Wexler, 2020) 3. Atorvastatin 40 mg by mouth once daily; According to Up to Date, “Statins such as atorvastatins are the most powerful drugs for lowering low-density lipoprotein cholesterol, with a reducing in the range of 30-63 percent” (Rosenson, 2020) 4. Lisinopril 5 mg by mouth once daily; According to Up to Date, “ACE inhibitors are the first line of drugs in patients with diabetes or systolic dysfunction and in patients with proteinuric chronic kidney disease” (Mann, 2020) 5. Heart healthy diet; According to Garber in the American Association of Clinical Endocrinologists, “Lifestyle therapy begins with nutrition which contains of heart healthy foods, low sodium, low fat, and reduced content of fat in diabetic and heart patients” (Garber, et al., 2019) 6. Exercise: According to Garber in the American Association of Clinical Endocrinologists, “Regular physical activity- both aerobic exercise and strength training- improves glucose control, lipid levels, and BP” (Garber, et al., 2019) 7. Record blood pressures; “Self monitoring and keeping a blood pressure diary at home may be associated with a modest reduction in systolic and diastolic blood pressure and possibly increased likelihood of achieving target blood pressure” (Dynamed, 2020) 8. No alcohol or smoking; According to Garber in the American Association of Clinical Endocrinologists “Smoking and alcohol cessation is an important component of lifestyle therapy and involves avoidance of all tobacco products and alcohol is important in reducing heart disease” (Garber et al., 2019) Non Pharmacolog